ACELRX PHARMACEUTICALS INC 4
4 · ACELRX PHARMACEUTICALS INC · Filed Mar 11, 2014
Insider Transaction Report
Form 4
KING RICHARD
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2014-03-02$11.43/sh−11,599$132,577→ 134,567 total
Footnotes (2)
- [F1]The Shares were withheld to satisfy tax liability upon vesting 25% of the restricted stock units of the Company previously reported on March 4, 2011.
- [F2]Balance includes non-reportable acquisition of 19,209 shares of Common Stock through the Company's Employee Stock Purchase Plan.